抄録
Defensin has been known as a major antimicrobial component of neutrophil granules. Recently, we have purified a novel cationic antibacterial polypeptide of 11 kDa (CAP11) from guinea pig neutrophilis. In this study, we have compared the biological activity and gene expression between CAP11 and defensin. When stimulated, CAP11 was extracellularly released from neutrophils, accompanied by the release of a specific granule component (lysozyme), whereas defensin was released, accompanied by the release of an azurophil granule component (β-glucoronidase) . Defensin modulated neutrophil functions such as adhesion, phagocytosis and superoxide anion generation. However, CAP11 did not affected the neutrophil functions. Both CAP11 and defensin possessed histamine-releasing activity for mast cells, but CAP11 was 10-fold less potent than defensins. CAP11 exhibited 8-fold more antibacterial activity against Escherichia coli than defensin, and the activity was retained even in the presence of physiological concentration of NaCl, although the activity of defensin was completely lost in the presence of NaCl. Sequence analysis of CAP11 cDNA showed that pre-prosequence of CAP11 was similar to the sequences of cathelicidin family polypeptides. Furthemore, in situ hybridization study revealed that CAP11 mRNA was highly expressed in metamyelocytes among bone marrow cells. In contrast, defensin mRNA was expressed in promyelocytes and myelocytes. Together these observations indicate that CAP11, a member of cathelicidin family, which is synthesized during the late stage of neutrophil maturation and stored possibly in the specific granules, is released from stimulated neutrophils and functions as an antibacterial molecule in the extracellular milieu, whereas defensin released from the azurophil granules likely participate in the modulation of neutrophil functions and mast cell histamine release.
